Abstract: A system and a computer-implemented method for analyzing workflow of test automation associated with a robotic process automation (RPA) application are disclosed herein. The computer-implemented method includes receiving the workflow of the test automation associated with the RPA application and analyzing, via an Artificial Intelligence (AI) model associated with a workflow analyzer module, the workflow of the test automation based on a set of pre-defined test automation rules. The computer-implemented method further includes determining one or more metrics associated with the analyzed workflow of the test automation and generating, via the AI model, corrective activity data based on the determined one or more metrics.

Abstract: A system and a computer-implemented method for analyzing a robotic process automation (RPA) workflow are disclosed herein. The computer-implemented method may include obtaining the RPA workflow and analyzing the obtained RPA workflow to provide an analyzed RPA workflow. The computer-implemented method may further include determining one or metrics associated with the analyzed RPA workflow and performing one or more corrective activities for the analyzed RPA workflow based on the determined one or more metrics.

Abstract: A robotic process automation (RPA) workflow may be automatically created from text, an image, and/or a media file. A workflow sequence may be converted into a digital format using optical character recognition (OCR), and this information may then be analyzed by an artificial intelligence (AI) model and converted into a predicted RPA workflow. The predicted RPA workflow may be presented to a developer for approval, denial, or modification. Information pertaining to the selection by the developer may then be used for subsequent retraining of the AI model to improve prediction accuracy.

Abstract: Automatic completion of robotic process automation (RPA) workflows using machine learning (ML) is disclosed. A trained ML model may intelligently and automatically predict and complete the next series of activities in RPA workflows (e.g., one, a few, many, the remainder of the workflow, etc.). Actions users take while creating workflows over a time period may be captured and stored. The ML model may then be trained and used to match the stored actions with stored workflow sequences of actions in order to predict and complete the workflow. As more and more workflow sequences are captured and stored over time, the ML model may be retrained to predict a larger number of sequences and/or to more accurately make predictions. Auto-completion may occur in real-time in some embodiments to save time and effort by the user.

Abstract: A method for managing operations of applications includes identifying a first application which is active on the electronic device and an event; and displaying an action element associated with a non-active second application on the first application based on the event. The action element of the second application is dynamically driven based on at least one among a context of the first application and a content of the first application.

Abstract: An electronic device includes a touch interface and a processor configured to identify a current touch displacement while a touch gesture of a user is received through the touch interface, to identify an action corresponding to a current state of the electronic device and the identified current touch displacement, and to perform a task according to the identified action.

Abstract: An electronic device includes a touch interface and a processor configured to identify a current touch displacement while a touch gesture of a user is received through the touch interface, to identify an action corresponding to a current state of the electronic device and the identified current touch displacement, and to perform a task according to the identified action.

Abstract: A method for managing operations of applications includes identifying a first application which is active on the electronic device and an event; and displaying an action element associated with a non-active second application on the first application based on the event. The action element of the second application is dynamically driven based on at least one among a context of the first application and a content of the first application.

Abstract: The invention provides compounds capable of treating against hepatitis infections, particularly hepatitis B viral infections. Compounds of the invention are nucleic acid-based and preferably comprise 2, 3, 4, 5 or 6 nucleoside units.

Abstract: The present invention discloses compounds of formula (I): which exhibit antiviral properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of anti-HBV treatment. The invention also relates to methods of treating a HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Abstract: The present invention relates to the design and use of a multipurpose reactor that may be adapted to accommodate a wide variety of solid phase and liquid phase reaction chemistries.

Abstract: The present invention comprises 7-deaza L-nucleosides having unexpectedly high inhibitory activity against the hepatitis B virus. The invention further comprises pharmaceutical compositions comprising such compounds as well as methods of treating mammals, particularly humans, infected with HBV and other viral infections.

Abstract: The present invention describes extremely rapid and efficient methods for the attachment of chemical moieties to matrices by the use of microwave technology. The methods of the invention can be applied in a variety of ways for the preparation of different types of matrices for a variety of applications including but not limited to the functionalization of various solid supports, and matrices in the form of powder, beads, sheets, and other suitable surfaces for use in applications including but not limited to oligonucleotide synthesis, peptide synthesis, environmental clean up (removal of toxic materials), immunoassays, affinity chromatography, combinatorial chemistry, microarrays, proteomics and medical diagnostics.

Abstract: The invention provides compounds capable of treating against hepatitis infections, particularly hepatitis B viral infections. Compounds of the invention are nucleic acid-based and preferably comprise 2, 3, 4, 5 or 6 nucleoside units.

Abstract: The invention provides new methods for synthesis of nucleotide-based compounds and new libraries of such compounds. Compounds of the invention are useful for a variety of therapeutic applications, including treatment of viral or bacterial infections and associated diseases and disorders.